Researchers adjusted for confounders like age, hypertension, cardiovascular disease, and other comorbidities. The refined results indicated GLP-1 users had a 16% lower risk of developing epilepsy ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

Neuroplasticity research shows that maternal brains are rewired for immense creativity and problem solving. How could GLP-1s ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

The results mark a setback for the hypothesis that drugs like semaglutide could provide a neuroprotective effect for patients ...

The researchers assessed the association between Alzheimer’s biomarkers and body mass index (BMI), according to a press ...

Weight loss drugs may still help to fight against Alzheimer’s disease, despite a study by the manufacturer of Ozempic showing ...